Literature DB >> 23657198

Limitless longevity: comment on the Contribution of rectangularization to the secular increase of life expectancy.

Karin Modig, Sven Drefahl, Anders Ahlbom.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23657198      PMCID: PMC3733697          DOI: 10.1093/ije/dyt035

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


× No keyword cloud information.
Rossi et al. looked at the increase in life expectancy in nine European countries, including Sweden, from 1922–2006. To do this, they used a method that allowed them to separate the two respective contributions to increased life expectancy of: (i) postponement of death, through rectangularization of the survival curve; and (ii) an upward shift in the maximum age at death, as a measure of longevity. They found that both factors have contributed to the increase in life expectancy in the nine countries in their study, but that increased longevity played a relatively greater role than postponement of death. They propose that changes in life-style factors, and particularly cigarette smoking, have been essential for rectangularizing the survival curve, but they have less specific suggestions for explaining the upward shift in the age at death in the countries included in their study. We previously analyzed mortality among Swedish centenarians in a cohort study based on individual data for all persons in Sweden who reached the age of 100 years from 1969–2009 (n = 15 231). In the analyses for this study we divided the data into a sequence of one-year cohorts. We used these data in an attempt to add some further insights to the findings by Rossi et al. We could indeed confirm that longevity, measured as the maximum age at death, has increased steadily during the period that we studied (Figure 1), and this was also shown by others for an earlier period. This corroborates Rossi and colleagues’ results, although their method of discrimination of the components of life expectancy leads to a slightly different definition of longevity than maximum age at death. Interestingly, however, there was no secular trend in the average age at death in our one-year cohorts of centenarians, either for males or for females. The mean age at death of females was ∼102 years throughout the 40-year period of the study, and about half a year less in males. This shows that the increase in maximum age at death was not caused by a decrease in mortality among the very oldest subjects in the study. Instead, the increase in maximum age at death was fueled by an increase in the number of people surviving to the age of 100 years; with a larger number of centenarians the probability that at least one dies at very old age also gets larger. A similar argument can be brought forward for the observations of Rossi et al. Declining mortality at younger ages eventually leads to rectangularization of the survival curve and thus to a greater number of individuals reaching higher ages. However, it will also lead to an increase in Rossi and colleagues’ chosen longevity measure, even in the case in which mortality rates at the higher ages have remained stable.
Figure 1

Highest age reached by cohort of centenarians (1969–2000)

Highest age reached by cohort of centenarians (1969–2000) Furthermore, our data suggest that the age-specific probabilities of dying may level off at some point closely above 100 years, rather than continuing to increase continuously with age. At the very end of life too few people remain in the population for proper estimations, but the observed figures would be consistent with one-year probabilities of dying stabilized at a level of about 0.5 (Figure 2). Such a level would be in agreement with previous reports, and the concept of probabilities of dying leveling off at old age would be consistent with the theory of heterogeneity of mortality introduced by Vaupel. At present there are no data available that allow an examination of mortality at much older ages, but such data will come. However, Gampe et al. have shown the leveling off of mortality after age 110 years through the use of combined data for many countries. It is perhaps natural to think of mortality as something that increases continuously with age and that the probability of dying eventually reaches 100% at a certain age, i.e., at the maximum life span. If, instead, probabilities of dying level off at old age, the maximum age at death will still increase steadily as long as the population that survives to old age increases as the result of decreased mortality at younger ages. One can only speculate about the age at which the probability of dying is no longer below 100 percent (we don't even know if a limit exists) or about the period for which the maximum age of dying may increase. The negative binomial distribution applied to persons who reach 100 years of age, with the annual probability of dying as a parameter, may provide a model for consideration.
Figure 2

Probability of dying for Swedish men and women over 100 years of age (1969–2009)

Probability of dying for Swedish men and women over 100 years of age (1969–2009) Our data are based on the Swedish experience of mortality, for which we know from official statistics that there are downward secular trends in mortality for age groups below 100 years, but as we have shown, not for age groups above this. At present we have less information about secular trends in centenarian mortality in countries other than Sweden. However, our key point, that longevity, defined as the maximum age of death, will continue to increase, is essentially independent of actual mortality trends among centenarians.

Funding

This study was funded by the Swedish Council for Working Life and Social Research (Swedish acronym: FAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Conflict of interest: None declared.
  4 in total

1.  Increase of maximum life-span in Sweden, 1861-1999.

Authors:  J R Wilmoth; L J Deegan; H Lundström; S Horiuchi
Journal:  Science       Date:  2000-09-29       Impact factor: 47.728

2.  The era of centenarians: mortality of the oldest old in Sweden.

Authors:  S Drefahl; H Lundström; K Modig; A Ahlbom
Journal:  J Intern Med       Date:  2012-02-20       Impact factor: 8.989

Review 3.  Biodemographic trajectories of longevity.

Authors:  J W Vaupel; J R Carey; K Christensen; T E Johnson; A I Yashin; N V Holm; I A Iachine; V Kannisto; A A Khazaeli; P Liedo; V D Longo; Y Zeng; K G Manton; J W Curtsinger
Journal:  Science       Date:  1998-05-08       Impact factor: 47.728

4.  The contribution of rectangularization to the secular increase of life expectancy: an empirical study.

Authors:  Isabelle A Rossi; Valentin Rousson; Fred Paccaud
Journal:  Int J Epidemiol       Date:  2012-12-21       Impact factor: 7.196

  4 in total
  8 in total

1.  Mortality Trajectories at Extreme Old Ages: A Comparative Study of Different Data Sources on U.S. Old-Age Mortality.

Authors:  Natalia S Gavrilova; Leonid A Gavrilov
Journal:  Living 100 Monogr       Date:  2014

2.  New Developments in the Biodemography of Aging and Longevity.

Authors:  Leonid A Gavrilov; Natalia S Gavrilova
Journal:  Gerontology       Date:  2014-12-20       Impact factor: 5.140

3.  Biodemography of old-age mortality in humans and rodents.

Authors:  Natalia S Gavrilova; Leonid A Gavrilov
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-02-17       Impact factor: 6.053

4.  Age-specific trends in morbidity, mortality and case-fatality from cardiovascular disease, myocardial infarction and stroke in advanced age: evaluation in the Swedish population.

Authors:  Karin Modig; Tomas Andersson; Sven Drefahl; Anders Ahlbom
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

5.  Does a hospital admission in old age denote the beginning of life with a compromised health-related quality of life? A longitudinal study of men and women aged 65 years and above participating in the Stockholm Public Health Cohort.

Authors:  Korinna Karampampa; Paolo Frumento; Anders Ahlbom; Karin Modig
Journal:  BMJ Open       Date:  2016-07-11       Impact factor: 2.692

6.  Focus on disability-free life expectancy: implications for health-related quality of life.

Authors:  Ashley E Galvin; Daniela B Friedman; James R Hébert
Journal:  Qual Life Res       Date:  2021-03-17       Impact factor: 4.147

7.  Losing ground--Swedish life expectancy in a comparative perspective.

Authors:  Sven Drefahl; Anders Ahlbom; Karin Modig
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

8.  Does improved survival lead to a more fragile population: time trends in second and third hospital admissions among men and women above the age of 60 in Sweden.

Authors:  Korinna Karampampa; Tomas Andersson; Sven Drefahl; Anders Ahlbom; Karin Modig
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.